Literature DB >> 9806411

Disturbances of loudness perception.

D P Phillips1, M M Carr.   

Abstract

This article reviews information on some auditory disorders that have in common a disturbance in loudness perception. The perceptual disturbances in these disorders have interchangeably been labeled "hyperacusis," "dysacusis," or "phonophobia." Our question concerns whether the loudness disturbances associated with these auditory disorders are sufficiently different as not to justify the equivalence implied by the labelling. Emphasis is placed on those articles that have given clear accounts of the phenomenology of the disturbed perceptual experience and have offered testable hypotheses about the mechanisms underlying it. Hypotheses about the origins of disturbed loudness perception are compared with independent experimental and clinical evidence on those mechanisms. The disturbances of loudness perception that occur in cochlear hearing loss, facial nerve paralysis and stapedectomy, and in more "central" disorders are phenomenologically different, have different underlying mechanisms, and merit different labels that most of them do not currently receive.

Entities:  

Mesh:

Year:  1998        PMID: 9806411

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  16 in total

1.  Auditory brainstem response (ABR) abnormalities across the life span of rats prenatally exposed to alcohol.

Authors:  Michael W Church; John W Hotra; Pamela A Holmes; Jennifer I Anumba; Desmond A Jackson; Brittany R Adams
Journal:  Alcohol Clin Exp Res       Date:  2011-08-04       Impact factor: 3.455

2.  Effects of Acoustic Environment on Tinnitus Behavior in Sound-Exposed Rats.

Authors:  Aikeen Jones; Bradford J May
Journal:  J Assoc Res Otolaryngol       Date:  2018-01-02

3.  Repeated antenatal corticosteroid treatments adversely affect neural transmission time and auditory thresholds in laboratory rats.

Authors:  M W Church; B R Adams; J I Anumba; D A Jackson; M L Kruger; K-L C Jen
Journal:  Neurotoxicol Teratol       Date:  2011-09-22       Impact factor: 3.763

4.  Early-life status epilepticus acutely impacts select quantitative and qualitative features of neonatal vocalization behavior: Spectrographic and temporal characterizations in C57BL/6 mice.

Authors:  Conner D Reynolds; Suzanne O Nolan; Jessica L Huebschman; Samantha L Hodges; Joaquin N Lugo
Journal:  Epilepsy Behav       Date:  2017-05-30       Impact factor: 2.937

5.  Low-frequency tone pips elicit exaggerated startle reflexes in C57BL/6J mice with hearing loss.

Authors:  James R Ison; Paul D Allen
Journal:  J Assoc Res Otolaryngol       Date:  2003-06-06

6.  Excess omega-3 fatty acid consumption by mothers during pregnancy and lactation caused shorter life span and abnormal ABRs in old adult offspring.

Authors:  M W Church; K-L C Jen; J I Anumba; D A Jackson; B R Adams; J W Hotra
Journal:  Neurotoxicol Teratol       Date:  2009-10-07       Impact factor: 3.763

7.  Abnormal neurological responses in young adult offspring caused by excess omega-3 fatty acid (fish oil) consumption by the mother during pregnancy and lactation.

Authors:  M W Church; K-L C Jen; D A Jackson; B R Adams; J W Hotra
Journal:  Neurotoxicol Teratol       Date:  2008-09-16       Impact factor: 3.763

8.  Psychometric Evaluation of the Short Sensory Profile in Youth with Autism Spectrum Disorder.

Authors:  Zachary J Williams; Michelle D Failla; Katherine O Gotham; Tiffany G Woynaroski; Carissa Cascio
Journal:  J Autism Dev Disord       Date:  2018-12

9.  A Phenotypic Comparison of Loudness and Pain Hyperacusis: Symptoms, Comorbidity, and Associated Features in a Multinational Patient Registry.

Authors:  Zachary J Williams; Evan Suzman; Tiffany G Woynaroski
Journal:  Am J Audiol       Date:  2021-04-20       Impact factor: 1.493

Review 10.  A review of decreased sound tolerance in autism: Definitions, phenomenology, and potential mechanisms.

Authors:  Zachary J Williams; Jason L He; Carissa J Cascio; Tiffany G Woynaroski
Journal:  Neurosci Biobehav Rev       Date:  2020-12-04       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.